- Condition: Cardiovascular Injury
Intervention:
Sponsors: Health Effects Institute; Health Effects Institute; New England Research Institutes; University of California, San Francisco; University of North Carolina, Chapel Hill; University of Rochester
Not yet recruiting - verified November 2011 - Condition: No Eye Disease
Intervention:
Sponsors: Optovue; Optovue
Completed - verified May 2012 - Conditions: Burns; Smoke Inhalation Injury
Interventions: Behavioral: Injury Prevention Briefing Plus facilitation; Behavioral: Injury Prevention Briefing
Sponsors: University of Nottingham; University of Nottingham
Recruiting - verified October 2011 - Condition: Keratoconus
Interventions: Procedure: Artemis Ultrasound Exam; Procedure: ARFI Ultrasound exam
Sponsors: Columbia University; Columbia University; National Eye Institute (NEI)
Recruiting - verified February 2012 - Condition: Heart Failure
Interventions: Drug: placebo; Drug: omecamtiv mecarbil; Drug: omecamtiv mecarbil; Drug: omecamtiv mecarbil; Drug: omecamtiv mecarbil; Drug: omecamtiv mecarbil; Drug: omecamtiv mecarbil; Drug: omecamtiv mecarbil; Drug: omecamtiv mecarbil; Drug: omecamtiv mecarbil; Drug: omecamtiv mecarbil
Sponsors: Cytokinetics; Cytokinetics
Completed - verified June 2011 - Condition: Chlamydia Trachomatis
Intervention: Device: APTIMA Assay for Chlamydia trachomatis
Sponsors: Gen-Probe, Incorporated; Gen-Probe, Incorporated
Completed - verified February 2012 - Condition: Dry Eye
Interventions: Other: Systane Balance Lubricating Eye Drops; Other: OPTIVE™
Sponsors: Alcon Research; Alcon Research; Optometric Technology Group Ltd
Completed - verified January 2012 - Condition: Traumatic Brain Injury (TBI)
Intervention: Other: Banyan Biomarkers
Sponsors: Banyan Biomarkers, Inc; Banyan Biomarkers, Inc
Completed - verified May 2012 - Condition: HIV Infections
Intervention: Biological: CN54gp140 glycoprotein-hsp70 conjugate vaccine
Sponsors: St George's, University of London; St George's, University of London; European Union
Active, not recruiting - verified October 2011 - Condition: N. Meningitidis Carriage
Interventions: Biological: Meningococcal vaccines; Biological: Meningococcal vaccines; Biological: Meningococcal vaccines
Sponsors: Novartis; Novartis Vaccines
Active, not recruiting - verified January 2012 - Conditions: Charcot-Marie-Tooth Disease, Type Ia (Disorder); HMSN
Intervention:
Sponsors: Wayne State University; Wayne State University; National Institute of Neurological Disorders and Stroke (NINDS); Muscular Dystrophy Association; University of Rochester; University of Pennsylvania; National Hospital for Neurology and Neurosurgery; The Childrens Hospital of Westmead; Children's Hospital of Philadelphia; University of Miami; Johns Hopkins University; University of Washington
Recruiting - verified October 2011 - Condition: Charcot Marie Tooth Disease
Intervention:
Sponsors: Wayne State University; Wayne State University; National Institute of Neurological Disorders and Stroke (NINDS); Muscular Dystrophy Association; National Hospital of Neurology and Neurosurgery, Queens Square, London, UK; The Children's Hospital at Westmead; University of Rochester; University of Miami; University of Pennsylvania; Childrens Hospital of Philadelphia; C. Besta Neurological Institute; Johns Hopkins University; University of Washington
Recruiting - verified October 2011 - Conditions: Defect of Articular Cartilage; Osteochondritis Dissecans
Interventions: Procedure: Microfracture; Device: Cartilage Autograft Implantation System
Sponsors: DePuy Mitek; DePuy Mitek
Recruiting - verified April 2012 - Condition: Osteoarthritis, Knee
Interventions: Radiation: MRI; Procedure: Primary Total Knee Replacement
Sponsors: The New England Baptist Hospital; The New England Baptist Hospital; Genzyme
Recruiting - verified June 2011 - Condition: Healthy
Intervention: Drug: Filgrastim
Sponsors: Center for International Blood and Marrow Transplant Research; Center for International Blood and Marrow Transplant Research; National Marrow Donor Program
Recruiting - verified February 2012 - Condition: Chronic Migraine
Interventions: Drug: propranolol LA; Drug: topiramate; Drug: placebo
Sponsors: The EMMES Corporation; Anne Lindblad; National Institute of Neurological Disorders and Stroke (NINDS); Ortho-McNeil Janssen Scientific Affairs, LLC
Completed - verified January 2012 - Condition: Pulmonary Embolism
Interventions: Drug: warfarin; Drug: Fondaparinux:; Drug: warfarin
Sponsors: The New England Baptist Hospital; The New England Baptist Hospital
Active, not recruiting - verified September 2011 - Conditions: Lumbar Spinal Stenosis; Neurogenic Intermittent Claudication
Interventions: Device: Superion™ Interspinous Spacer; Device: X-STOP® IPD® Device
Sponsors: VertiFlex, Incorporated; VertiFlex, Incorporated
Recruiting - verified November 2011 - Condition: Choroidal Melanoma
Intervention: Procedure: Ranibizumab injection and TTT - ICG based
Sponsors: New England Retina Associates; New England Retina Associates
Active, not recruiting - verified August 2011 - Condition: Thalassemia
Intervention:
Sponsors: New England Research Institutes; New England Research Institutes; National Heart, Lung, and Blood Institute (NHLBI); Thalassemia Clinical Research Network
Completed - verified June 2011 - Condition: Breast Cancer
Interventions: Genetic: gene expression analysis; Genetic: molecular diagnostic method; Genetic: polymorphism analysis; Genetic: protein expression analysis; Other: medical chart review; Other: questionnaire administration
Sponsors: National Cancer Institute (NCI); National Cancer Research Network
Recruiting - verified September 2007 - Condition: Healthy
Interventions: Biological: MEDI-560; Biological: Placebo
Sponsors: MedImmune LLC; MedImmune LLC
Terminated - verified November 2011 - Conditions: Respiratory Viral Infections; Respiratory Syncytial Virus Infections; Parainfluenza Virus 3, Human
Interventions: Biological: MEDI-534; Biological: MEDI-534; Biological: MEDI-534
Sponsors: MedImmune LLC; MedImmune LLC
Completed - verified March 2012 - Condition: Healthy
Interventions: Biological: MEDI-524; Other: Placebo
Sponsors: MedImmune LLC; MedImmune LLC
Completed - verified October 2011 - Condition: Diethylstilbestrol (DES) Exposure
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Active, not recruiting - verified October 2011 - Condition: Women's Health
Intervention: Behavioral: Caring for Women Veterans
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Completed - verified April 2006 - Condition: Breast Cancer
Intervention: Drug: anastrozole
Sponsors: Queen Mary University of London; Jill Knox
Active, not recruiting - verified April 2012 - Condition: Leukemia
Interventions: Biological: filgrastim; Drug: asparaginase; Drug: cyclophosphamide; Drug: cyclosporine; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: dexamethasone; Drug: etoposide; Drug: ifosfamide; Drug: imatinib mesylate; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: pegaspargase; Drug: vincristine sulfate; Procedure: allogeneic bone marrow transplantation; Procedure: peripheral blood stem cell transplantation; Procedure: umbilical cord blood transplantation; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified November 2010
 |
Join Clinical Trials for Healthy Volunteers in England |
